Tango TherapeuticsTNGX
那斯達克 · USD
28.29
-0.39
(-1.36%)
盤中 06/11 10:52 (UTC+8)
06/11 10:52 (UTC+8)
Tango TherapeuticsTNGX
28.29
-0.39
(-1.36%)
財務數據
損益表
- 0.05
- 0.06
- 0.20
- 0.12
- 0.04
- 0.05
- 0.03
- 0.54
- -
- -
- -49.39
- 19.15
- 207.14
- -41.61
- -64.53
- 30.97
- -41.01
- 1591.64
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | 53,811 | 3,181 | 5,392 | 4,117 | 11,606 | 19,875 | 6,471 | 5,431 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | 53,811 | 3,181 | 5,392 | 4,117 | 11,606 | 19,875 | - | 5,431 |
營業費用 | 48,769 | 41,864 | 39,739 | 44,148 | 47,922 | 45,027 | 44,484 | 49,427 | - | 40,444 |
研發費用 | 33,534 | 32,101 | 30,815 | 32,807 | 36,442 | 33,937 | 33,262 | 38,654 | 38,065 | 31,339 |
推銷及管理費用 | 15,235 | 9,763 | 8,924 | 11,341 | 11,480 | 11,090 | 11,222 | 10,773 | 10,661 | 9,105 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -48,769 | -41,864 | 14,072 | -40,967 | -42,530 | -40,910 | -32,878 | -29,552 | -42,255 | -35,013 |
其他收入及費用 | 3,256 | 3,060 | 1,802 | 2,149 | 2,688 | 3,289 | 3,765 | 4,066 | 4,381 | 4,297 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -45,513 | -38,804 | 15,874 | -38,818 | -39,842 | -37,621 | -29,113 | -25,486 | -37,874 | -30,716 |
所得稅 | 1 | -55 | -10 | 35 | 34 | 49 | 54 | 65 | 40 | 47 |
稅後純益 | -45,514 | -38,749 | 15,884 | -38,853 | -39,876 | -37,670 | -29,167 | -25,551 | -37,914 | -30,763 |
基本每股稅後盈餘(元) | -0.32 | -0.29 | 0.14 | -0.35 | -0.36 | -0.35 | -0.27 | -0.24 | -0.35 | - |
稀釋每股稅後盈餘(元) | -0.32 | -0.30 | 0.13 | -0.35 | -0.36 | -0.34 | -0.27 | -0.23 | -0.35 | -0.30 |
基本平均股數(千股) | 143576.00 | 131590.00 | 110966.00 | 110540.00 | 110301.00 | 108683.00 | 108507.00 | 108314.00 | 108171.00 | - |
稀釋平均股數(千股) | 143576.00 | 131590.00 | 117782.00 | 110540.00 | 110301.00 | 108683.00 | 108507.00 | 108314.00 | 108171.00 | - |
還原基本每股稅後盈餘(元) | -0.32 | -0.29 | 0.14 | -0.35 | -0.36 | -0.35 | -0.27 | -0.24 | -0.35 | - |
還原稀釋每股稅後盈餘(元) | -0.32 | -0.30 | 0.13 | -0.35 | -0.36 | -0.34 | -0.27 | -0.23 | -0.35 | -0.30 |
還原基本平均股數(千股) | 143,576 | 131,590 | 110,966 | 110,540 | 110,301 | 108,683 | 108,507 | 108,314 | 108,171 | - |
還原稀釋平均股數(千股) | 143,576 | 131,590 | 117,782 | 110,540 | 110,301 | 108,683 | 108,507 | 108,314 | 108,171 | - |
EBITDA(千元) | -46,174 | -39,093 | 15,869 | -38,915 | -39,858 | -37,857 | -29,677 | -26,058 | -38,620 | -32,463 |